Please assess the completion status of the following clinical trial:

Trial Title: Misopristol Versus Pitocin for Second Trimester Abortion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* midtrimester late abortion~* midtrimester induced abortion~Exclusion Criteria:~* placenta previa~* infected abortion~* rupture of membranes~* s/p cesarean section \*2 or more

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- pitocin (Type: ACTIVE_COMPARATOR): high dose pitocin drip 48 hours after mifepristone preparation.
- misopristol (Type: ACTIVE_COMPARATOR): vaginal and oral misopristol 48 hours after mifepristone preparation.

Based on this trial design, predict the completion outcome and termination type (if applicable).